Shenyang Xingqi Pharmaceutical Co., Ltd., Shenyang, People's Republic of China .
J Ocul Pharmacol Ther. 2018 Jul/Aug;34(6):460-467. doi: 10.1089/jop.2017.0139. Epub 2018 May 24.
To investigate the ocular penetration of natamycin (NAT) and voriconazole (VRC) after topical instillation in New Zealand white rabbits using simplified liquid chromatography-tandem mass spectrometry (LC-MS/MS) and high-performance liquid chromatography.
Seventy-eight healthy rabbits were randomly divided into 3 groups. In the first 2 groups, 72 rabbits were used for single-dose testing (36 for NAT, 36 for VRC), in which 50 μL of 5.0% NAT or 1.0% VRC was instilled into the rabbits' left eyes. In the 3rd group, 6 rabbits were used for repeated-dose testing in which 50 μL of 5.0% NAT was instilled into their left eyes 12 times (once per hour) during the daytime. These animals were sacrificed immediately to collect their aqueous humors and corneas.
After a single topical instillation, the highest concentrations in the cornea and aqueous humor for VRC were 34.1 μg/g and 14.7 μg/mL, respectively. The permeability ratios of aqueous/cornea were from 0.1 to 1.26. The highest concentrations in cornea and aqueous humor for NAT were 299.3 ng/g and 27.1 ng/mL, respectively. The permeability ratios of aqueous/cornea were from 0.02 to 0.23. In the repeated-dose group, the NAT concentrations in the cornea and aqueous humor were 10,569 ng/g and 54.4 ng/mL, respectively. The permeability ratio was as low as 0.0051.
The better corneal penetration of VRC suggests that it is more suitable for deep corneal fungal infections than NAT via topical ocular administration.
使用简化液相色谱-串联质谱(LC-MS/MS)和高效液相色谱法研究新西兰白兔局部滴注那他霉素(NAT)和伏立康唑(VRC)后的眼部穿透率。
78 只健康兔随机分为 3 组。前 2 组中,36 只用于单剂量试验(NAT 组 36 只,VRC 组 36 只),其中 50 μL 5.0% NAT 或 1.0% VRC 滴注入兔子左眼。第 3 组中,6 只用于重复剂量试验,在白天期间,12 次(每小时 1 次)向其左眼滴注 50 μL 5.0% NAT。这些动物被立即处死以收集房水和角膜。
单次局部滴注后,VRC 在角膜和房水中的最高浓度分别为 34.1μg/g 和 14.7μg/mL。水/角膜的渗透比为 0.1 至 1.26。NAT 在角膜和房水中的最高浓度分别为 299.3ng/g 和 27.1ng/mL。水/角膜的渗透比为 0.02 至 0.23。在重复剂量组中,NAT 在角膜和房水中的浓度分别为 10569ng/g 和 54.4ng/mL。渗透比低至 0.0051。
VRC 更好的角膜穿透性表明,与局部眼部给药相比,它更适合深部角膜真菌感染。